In last trading session, ARCA biopharma Inc (NASDAQ:ABIO) saw 0.35 million shares changing hands with its beta currently measuring 1.09. Company’s recent per share price level of $3.23 trading at -$0.02 or -0.62% at ring of the bell on the day assigns it a market valuation of $46.84M. That closing price of ABIO’s stock is at a discount of -20.12% from its 52-week high price of $3.88 and is indicating a premium of 51.7% from its 52-week low price of $1.56. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 8.61 million shares which gives us an average trading volume of 1.41 million if we extend that period to 3-months.
ARCA biopharma Inc (NASDAQ:ABIO) trade information
Upright in the red during last session for losing -0.62%, in the last five days ABIO remained trading in the green while hitting it’s week-highest on Tuesday, 04/09/24 when the stock touched $3.23 price level, adding 3.0% to its value on the day. ARCA biopharma Inc’s shares saw a change of 90.00% in year-to-date performance and have moved 4.53% in past 5-day. ARCA biopharma Inc (NASDAQ:ABIO) showed a performance of 91.12% in past 30-days. Number of shares sold short was 0.2 million shares which calculate 7.31 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 48.59% during past 5 years.
ABIO Dividends
ARCA biopharma Inc is more likely to be releasing its next quarterly report in May and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
ARCA biopharma Inc (NASDAQ:ABIO)’s Major holders
Insiders are in possession of 1.29% of company’s total shares while institution are holding 57.01 percent of that, with stock having share float percentage of 57.76%. Investors also watch the number of corporate investors in a company very closely, which is 57.01% institutions for ARCA biopharma Inc that are currently holding shares of the company. Bml Capital Management, Llc is the top institutional holder at ABIO for having 0.71 million shares of worth $1.44 million. And as of Jun 29, 2023, it was holding 4.91% of the company’s outstanding shares.
The second largest institutional holder is Western Standard, LLC, which was holding about 0.63 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 4.37% of outstanding shares, having a total worth of $1.28 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 0.31 million shares of worth $0.63 million or 2.17% of the total outstanding shares. The later fund manager was in possession of 0.14 million shares on Jun 29, 2023, making its stake of worth around $0.28 million in the company or a holder of 0.96% of company’s stock.
